Rani Therapeutics Holdings (RANI) Change in Acquisitions & Divestments (2022 - 2026)

Rani Therapeutics Holdings' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $21.0 million for Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments changed 0.0% to $21.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $26.8 million, a 65.79% decrease, with the full-year FY2025 number at $26.8 million, down 65.51% from a year prior.
  • Change in Acquisitions & Divestments came in at $21.0 million for Q1 2026, up from $5.8 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $35.0 million in Q2 2023, with the low at $3.0 million in Q4 2022.
  • Historically, Change in Acquisitions & Divestments has averaged $19.4 million across 5 years, with a median of $20.7 million in 2024.
  • Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 661.67% in 2023 and later plummeted 68.41% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $3.0 million in 2022, then soared by 661.67% to $22.8 million in 2023, then decreased by 11.16% to $20.3 million in 2024, then tumbled by 71.67% to $5.8 million in 2025, then skyrocketed by 265.22% to $21.0 million in 2026.
  • Business Quant data shows Change in Acquisitions & Divestments for RANI at $21.0 million in Q1 2026, $5.8 million in Q2 2025, and $21.0 million in Q1 2025.